Regulation of cytosolic PlA2 activity by PP1/PP2A serine/threonine phosphatases in human platelets

Platelets

Volumn 17, Issue 6, 2006, Pages 405-415

  Moscardó, Antonio ^a   Vallés, Juana ^a   Piñón, Marta ^a   Aznar, Justo ^a   Martínez Sales, Vicenta ^a   Santos, María Teresa ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Cytosolic PLA2; Platelets; Serine threonine phosphatases PP1 PP2A; Tyrosine phosphorylation

Indexed keywords

OKADAIC ACID; PHOSPHATASE; PP1 ENZYME; PP2A ENZYME; SERINE PHOSPHATASE; THREONINE PHOSPHATASE; THROMBOXANE A2; UNCLASSIFIED DRUG; CALCIUM; PHOSPHOLIPASE A; PHOSPHOLIPASE A2 ALPHA; PHOSPHOLIPASE A2-ALPHA; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN SERINE THREONINE PHOSPHATASE; PROTEIN-SERINE-THREONINE PHOSPHATASE;

ARTICLE; CELL MEMBRANE; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; THROMBOCYTE; THROMBOCYTE AGGREGATION; CYTOSOL; ENZYMOLOGY; IN VITRO STUDY; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY;

BLOOD PLATELETS; CALCIUM; CYTOSOL; HUMANS; OKADAIC ACID; PHOSPHOLIPASES A; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHORYLATION; PLATELET AGGREGATION; THROMBOXANE A2;

EID: 33748768974     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537100600757869     Document Type: Article

References (40)

1. Marcus AJ. Platelets: Their role in hemostasis, thrombosis and inflammation. In: Gallin JI, Snyderman R, editors. Inflammation: Basic principles and clinical correlates. Philadelphia, PA: Lippincott Williams & Wilkins; 1999. pp 77-95.
2. Santos MT, Valles J, Marcus AJ, Safier LB, Broekman MJ, Islam N, Ullman HL, Eiroa AM, Aznar J. Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. J Clin Invest 1991;87:571-580.
3. Valles J, Santos MT, Marcus AJ, Safier LB, Broekman MJ, Islam N, Ullman HL, Aznar J. Downregulation of human platelet reactivity by neutrophils. Participation of lipoxygenase derivatives and adhesive proteins. J Clin Invest 1993;92:1357-1365.
4. 3 integrin receptor activation and P-selectin expression during platelet recruitment: Downregulation by aspirin ex vivo. Blood 2002;99:3978-3984.
5. Brash AR. Arachidonic acid as a bioactive molecule. J Clin Invest 2001;107:1339-1345.
6. Barry OP, Pratico D, Lawson JA, FitzGerald GA. Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J Clin Invest 1997;99:2118-2127.
7. 2+ channel in human erythrocytes. Blood 2000;95:2420-2425.
8. 2. J Lipid Mediat Cell Signal 1995;12:83-117.
9. 2. J Biol Chem 1997;272:16709-16712.
10. 2, a regulatory Ca(2+)-dependent lipid-binding domain and a Ca(2+)-independent catalytic domain. J Biol Chem 1994;269:18239-18249.
11. 2 is phosphorylated and activated by MAP kinase. Cell 1993;72:269-278.
12. 2 by MNK1-related protein kinases. J Biol Chem 2000;275:37542-37551.
13. Berridge MJ. Capacitative calcium entry. Biochem J 1995;312:1-11.
14. Sage SO. The Wellcome Prize Lecture - Calcium entry mechanisms in human platelets. Exp Physiol 1997;82:807-823.
15. Rosado JA, Porras T, Conde M, Sage SO. Cyclic nucleotides modulate store-mediated calcium entry through the activation of protein-tyrosine phosphatases and altered actin polymerization in human platelets. J Biol Chem 2001;276:15666-15675.
16. Jackson SP, Schoenwaelder SM, Yuan YP, Salem HH, Cooray P. Non-receptor protein tyrosine kinases and phosphatases in human platelets. Thromb Haemost 1996;76:640-650.
17. Levy-Toledano S, Gallet C, Nadal F, Bryckaert M, Maclouf J, Rosa JP. Phosphorylation and dephosphorylation mechanisms in platelet function: A tightly regulated balance. Thromb Haemost 1997;78:226-233.
18. Fernandez JJ, Candenas ML, Souto ML, Trujillo MM, Norte M. Okadaic acid, useful tool for studying cellular processes. Curr Med Chem 2002;9:229-262.
19. Cohen P, Holmes CFB, Tsukitani Y. Okadaic acid: A new probe for the study of cellular regulation. Trends Biochem Sci 1990;15:98-102.
20. Dounay AB, Forsyth CJ. Okadaic acid: The archetypal serine/threonine protein phosphatase inhibitor. Curr Med Chem 2002;9:1939-1980.
21. Artcanuthurry V, Grelac F, Maclouf J, Martin-Cramer E, Levy-Toledano S. Serine/threonine dephosphorylation may be involved in tyrosine phosphorylation: A new mode of signal transduction in platelets. Semin Thromb Hemost 1996;22:317-326.
22. Mauco G, Artcanuthurry V, Pidard D, Grelac F, Maclouf J, Levy-Toledano S. Total inhibition of phospholipase C and phosphatidylinositol 3-kinase by okadaic acid in thrombinstimulated platelets. Cell Signal 1997;9:117-124.
23. Lerea KM. Thrombin-induced effects are selectively inhibited following treatment of intact human platelets with okadaic acid. Biochemistry 1991;30:6819-6824.
24. Chiang TM. The role of protein phosphatases 1 and 2A in collagen-platelet interaction. Arch Biochem Biophys 1993;302:56-63.
25. Sundaresan P, Farndale RW. p38 mitogen-activated protein kinase dephosphorylation is regulated by protein phosphatase 2A in human platelets activated by collagen. FEBS Lett 2002;528:139-144.
26. Abel K, Mieskes G, Walter U. Dephosphorylation of the focal adhesion protein VASP in vitro and in intact human platelets. FEBS Lett 1995;370:184-188.
27. 3 integrin receptor activation, and aspirin-insensitive mechanisms of thrombin-stimulated human platelets. Circulation 2000;102:1924-1930.
28. Levitzk A, Gazit A. Tyrosine kinase inhibition: An approach to drug development. Science 1995;267:1782-1788.
29. Valles J, Santos MT, Aznar J, Marcus AJ, Martinez-Sales V, Portoles M, Broekman MJ, Safier LB. Erythrocytes metabolically enhance collagen-induced platelet responsiveness via increased thromboxane production, ADP release, and recruitment. Blood 1991;78:154-162.
30. 2 in human platelets. J Biol Chem 1993;268:26796-26804.
31. 2+-ATPases. Br J Haematol 1998;102:850-859.
32. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985;260:3440-3450.
33. 2+-ATPase. Proc Natl Acad Sci USA 1990;87:2466-2470.
34. 2+ store depletion in human platelets. Cell Calcium 1994;15:381-390.
35. 2+ entry and protein-tyrosine phosphorylation are inhibited by the tyrosine kinase inhibitors genistein and methyl-2,5-dihydroxycinnamate in Fura-2-loaded human platelets. J Biol Chem 1993;268:18151-18156.
36. Huijsduijnen RH, Walchli S, Ibberson M, Harrenga A. Protein tyrosine phosphatases as drug targets: PTP1B and beyond. Expert Opin Ther Targets 2002;6:637-647.
37. Pumiglia KM, Lau LF, Huang CK, Burroughs S, Feinstein MB. Activation of signal transduction in platelets by the tyrosine phosphatase inhibitor pervanadate (vanadyl hydroperoxide). Biochem J 1992;286:441-449.
38. Gijon MA, Spencer DM, Kaiser AL, Leslie CC. Role of phosphorylation sites and the C2 domain in regulation of cytosolic phospholipase A2. J Cell Biol 1999; 145:1219-1232.
39. 2+-transients in human platelets. Role of a cdc2-related protein kinase. Biochemistry 1992;31:6553-6561.
40. Brautigan DL, Pinault FM. Serine phosphorylation of protein tyrosine phosphatase (PTP 1B) in HeLa cells in response to analogues of cAMP or diacylglycerol plus okadaic acid. Mol Cell Biochem 1993;127-128:121-129.